![](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAA5kAAANaCAIAAACMSB9rAAAACXBIWXMAABYlAAAWJQFJUiTwAAAPkUlEQVR42u3a0ankUAxEQfXi/FPW5iAPMuJVJXChf3QMrgIAgJtSVd299Fiy9taN9Q1iEACcIVfyxSb/rAAAwFFaFgAALQsAAFoWAAC0LAAAWhYAALQsAABoWQAAtCwAAGhZAADQsgAAoGUBANCyAACgZQEAQMsCAKBlAQBAywIAgJYFAAAtCwCAlgUAAC0LAABaFgAALQsAAFoWAAC0LAAAaFkAALQsAABoWQAA0LIAAGhZAADQsgAAoGUBAEDLAgCgZQEAQMsCAMBbqaruXnossTgAAL/yLL+31s03viQSgxgEAGfIlRxv4h8DAACu0rIAAGhZAADQsgAAoGUBANCyAACgZQEAQMsCAKBlAQBAywIAgJYFAAAtCwCAlgUAAC0LAABaFgAALQsAAFoWAAC0LAAAaFkAALQsAABoWQAA0LIAAGhZAADQsgAAoGUBAEDLAgCgZQEAQMsCAICWBQBAywIAgJYFAAAtCwAAWhYAAC0LAABaFgAAtCwAAFoWAAC0LAAAaFkAANCyAABoWQAA0LIAAKBlAQDQsgAAoGUBAEDLAgCAlgUAQMsCAICWBQAALQsAgJYFAAAtCwAAWhYAALQsAABaFgAAtCwAAGhZAAC0LAAAaFkAANCyAACgZQEA0LIAAKBlAQBAywIAoGUBAEDLAgCAlgUAAC0LAICWBQAALQsAAFoWAIC/JVXV3UuPJRYHAOBXnuX31rr5xpdEYhCDAOAMuZLjTfxjAADAVVoWAAAtCwAAWhYAALQsAABaFgAAtCwAAGhZAAC0LAAAaFkAANCyAACgZQEA0LIAAKBlAQBAywIAoGUBAEDLAgCAlgUAAC0LAICWBQAALQsAAFoWAAAtCwAAWhYAALQsAABoWQAAtCwAAGhZAADQsgAAaFkAANCyAACgZQEAQMsCAKBlAQBAywIAwFupqu5eeixZe+vG+okRAADGHhN8S9z72gHAGXIlx5v4xwAAgKu0LAAAWhYAALQsAABoWQAAtCwAAGhZAADQsgAAaFkAANCyAACgZQEAQMsCAKBlAQBAywIAgJYFAEDLAgCAlgUAAC0LAABaFgAALQsAAFoWAAC0LAAAWhYAALQsAABoWQAA0LIAAGhZAADQsgAAoGUBANCyAACgZQEAQMsCAICWBQBAywIAgJYFAAAtCwCAlgUAAC0LAABaFgAAtCwAAFoWAAC0LAAAaFkAALQsAABoWQAA0LIAAKBlAQDQsgAAoGUBAEDLAgCgZQEAQMsCAICWBQAALQsAgJYFAAAtCwAAWhYAAC0LAABaFgAAtCwAAGhZAAC0LAAAaFkAANCyAABoWQAA0LIAAKBlAQBAywIAoGUBAEDLAgDATKqqu5ceSywOAMCvPMvvrXXzjS+JxCAGAcAZciXHm/jHAACAq7QsAABaFgAAtCwAAGhZAAC0LAAAaFkAANCyAABoWQAA0LIAAKBlAQBAywIAoGUBAEDLAgCAlgUAQMsCAICWBQAALQsAAFoWAAAtCwAAWhYAALQsAABaFgAAtCwAAGhZAADQsgAAaFkAANCyAACgZQEA0LIAAKBlAQBAywIAgJYFAEDLAgCAlgUAgLdSVd299Fiy9taN9RMjAACMPSb4lrj3tQOAM+RKjjfxjwEAAFdpWQAAtCwAAGhZAADQsgAAaFkAANCyAACgZQEA0LIAAKBlAQBAywIAgJYFAEDLAgCAlgUAAC0LAICWBQAALQsAAFoWAAC0LAAAWhYAALQsAABoWQAAtCwAAGhZAADQsgAAoGUBANCyAACgZQEAQMsCAKBlAQBAywIAgJYFAAAtCwCAlgUAAC0LAABvpaq6e+mxZO2tG+snRgAAGHtM8C1x72sHAGfIlRxv4h8DAACu0rIAAGhZAADQsgAAoGUBANCyAACgZQEAQMsCAKBlAQBAywIAgJYFAAAtCwCAlgUAAC0LAABaFgAALQsAAFoWAAC0LAAAaFkAALQsAABoWQAA0LIAAGhZAADQsgAAoGUBAEDLAgCgZQEAQMsCAICWBQBAywIAgJYFAAAtCwAAWhYAAC0LAABaFgAA3kpVdffSY8naWzfWT4wAADD2mOBb4t7XDgDOkCs53sQ/BgAAXKVlAQDQsgAAoGUBAEDLAgCgZQEAQMsCAICWBQBAywIAgJYFAAAtCwAAWhYAAC0LAABaFgAAtCwAAFoWAAC0LAAAaFkAANCyAABoWQAA0LIAAKBlAQDQsgAAoGUBAEDLAgCAlgUAQMsCAICWBQAALQsAgJYFAAAtCwAAWhYAALQsAABaFgAAtCwAALyVqurupceStbdurJ8YAQBg7DHBt8S9rx0AnCFXcryJfwwAALhKywIAoGUBAEDLAgCAlgUAQMsCAICWBQAALQsAgJYFAAAtCwAAWhYAALQsAABaFgAAtCwAAGhZAAC0LAAAaFkAANCyAACgZQEA0LIAAKBlAQBAywIAoGUBAEDLAgCAlgUAAC0LAICWBQAALQsAAFoWAAAtCwAAWhYAALQsAABoWQAAtCwAAGhZAAB4K1XV3UuPJWtv3Vg/MQIAwNhjgm+Je187ADhDruR4E/8YAABwlZYFAEDLAgCAlgUAAC0LAICWBQAALQsAAFoWAAAtCwAAWhYAALQsAABoWQAAtCwAAGhZAADQsgAAaFkAANCyAACgZQEAQMsCAKBlAQBAywIAgJYFAEDLAgCAlgUAAC0LAABaFgAALQsAAFoWAAC0LAAAWhYAALQsAABoWQAA0LIAAGhZAADQsgAA8FaqqruXHkvW3rqxfmIEAICxxwTfEve+dgBwhlzJ8Sb+MQAA4CotCwCAlgUAAC0LAABaFgAALQsAAFoWAAC0LAAAWhYAALQsAABoWQAA0LIAAGhZAADQsgAAoGUBANCyAACgZQEAQMsCAICWBQBAywIAgJYFAAAtCwCAlgUAAC0LAABaFgAAtCwAAFoWAAC0LAAAaFkAALQsAABoWQAA0LIAAKBlAQDQsgAAoGUBAOCtVFV3Lz2WrL11Y/3ECAAAY48JviXufe0A4Ay5kuNN/GMAAMBVWhYAAC0LAABaFgAAtCwAAFoWAAC0LAAAaFkAALQsAABoWQAA0LIAAKBlAQDQsgAAoGUBAEDLAgCgZQEAQMsCAICWBQAALQsAgJYFAAAtCwAAWhYAAC0LAABaFgAAtCwAAGhZAAC0LAAAaFkAANCyAABoWQAA0LIAAKBlAQBAywIAoGUBAEDLAgCAlgUAQMsCAICWBQAALQsAAFoWAAAtCwAAWhYAALQsAABaFgAAtCwAAGhZAADQsgAAaFkAANCyAACgZQEA0LIAAHBHqqq7lx5L1t66sX5iBACAsccE3xL3vnYAcIZcyfEm/jEAAOAqLQsAgJYFAAAtCwAAWhYAAC0LAABaFgAAtCwAAFoWAAC0LAAAaFkAANCyAABoWQAA0LIAAKBlAQDQsgAAoGUBAEDLAgCAlgUAQMsCAICWBQAALQsAgJYFAAAtCwAAWhYAALQsAABaFgAAtCwAAGhZAAC0LAAAaFkAANCyAACgZQEA0LIAAKBlAQBAywIAoGUBAEDLAgCAlgUAAC0LAICWBQAALQsAAFoWAAAtCwAAWhYAALQsAABoWQAAtCwAAGhZAADQsgAAaFkAALgjVdXdS48la2/dWD8xAgDA2GOCb4l7XzsAOEOu5HgT/xgAAHCVlgUAQMsCAICWBQAALQsAgJYFAAAtCwAAWhYAAC0LAABaFgAAtCwAAGhZAAC0LAAAaFkAANCyAABoWQAA0LIAAKBlAQBAywIAoGUBAEDLAgCAlgUAQMsCAICWBQAALQsAAFoWAAAtCwAAWhYAALQsAABaFgAAtCwAAGhZAADQsgAAaFkAANCyAADwVqqqu5ceS9beurF+YgQAgLHHBN8S9752AHCGXMnxJv4xAADgKi0LAICWBQAALQsAAFoWAAAtCwAAWhYAALQsAABaFgAAtCwAAGhZAADQsgAAaFkAANCyAACgZQEA0LIAAKBlAQBAywIAgJYFAEDLAgCAlgUAAC0LAICWBQAALQsAAFoWAAC0LAAAWhYAALQsAABoWQAAtCwAAGhZAADQsgAAoGUBANCyAACgZQEAQMsCAKBlAQBAywIAgJYFAAAtCwCAlgUAAC0LAABaFgAALQsAAFoWAAC0LAAAaFkAALQsAABoWQAA0LIAAGhZAAC4I1XV3UuPJWtv3Vg/MQIAwNhjgm+Je187ADhDruR4E/8YAABwlZYFAEDLAgCAlgUAAC0LAICWBQAALQsAAFoWAAAtCwAAWhYAALQsAABoWQAAtCwAAGhZAADQsgAAaFkAANCyAACgZQEAQMsCAKBlAQBAywIAgJYFAEDLAgCAlgUAAC0LAABaFgAALQsAAFoWAAC0LAAAWhYAALQsAABoWQAA0LIAAGhZAADQsgAA8FaqqruXHkvW3rqxfmIEAICxxwTfEve+dgBwhlzJ8Sb+MQAA4CotCwCAlgUAAC0LAABaFgAALQsAAFoWAAC0LAAAWhYAALQsAABoWQAA0LIAAGhZAADQsgAAoGUBANCyAACgZQEAQMsCAICWBQBAywIAgJYFAAAtCwCAlgUAAC0LAABaFgAAtCwAAFoWAAC0LAAAaFkAALQsAABoWQAA0LIAAKBlAQDQsgAAoGUBAOCtVFV3Lz2WWBwAgF95lt9b6+YbXxKJQQwCgDPkSo438Y8BAABXaVkAALQsAABoWQAA0LIAAGhZAADQsgAAoGUBANCyAACgZQEAQMsCAICWBQBAywIAgJYFAAAtCwCAlgUAAC0LAABaFgAAtCwAAFoWAAC0LAAAaFkAALQsAABoWQAA0LIAAKBlAQDQsgAAoGUBAEDLAgCgZQEAQMsCAICWBQAALQsAgJYFAAAtCwAAb6WqunvpsWTtrRvrJ0YAABh7TPAtce9rBwBnyJUcb+IfAwAArtKyAABoWQAA0LIAAKBlAQDQsgAAoGUBAEDLAgCgZQEAQMsCAICWBQAALQsAgJYFAAAtCwAAWhYAAC0LAABaFgAAtCwAAGhZAAC0LAAAaFkAANCyAABoWQAA0LIAAKBlAQBAywIAoGUBAEDLAgCAlgUAQMsCAICWBQAALQsAAFoWAAAtCwAAWhYAALQsAABaFgAAtCwAAGhZAADQsgAAaFkAANCyAACgZQEA0LIAAKBlAQBAywIAgJYFAEDLAgCAlgUAAC0LAICWBQAALQsAAFoWAAC0LAAAWhYAALQsAABoWQAAtCwAAGhZAADQsgAAoGUBANCyAACgZQEAQMsCAKBlAQBAywIAgJYFAAAtCwCAlgUAAC0LAAAAAPC3/AfeBlzRlCDv9AAAAABJRU5ErkJggg==)
BA0-9
肢 9-1-3
一下肢足踝關節缺失者。 6 50%
縮短障害
(註 11)
9-2-1
一下肢永久縮短五公分以上者。 7 40%
足趾缺損
障害
(註 12)
9-3-1
雙足十趾均缺失者。 5 60%
9-3-2
一足五趾均缺失者。 7
40%
下肢機能
障害
(註 13)
9-4-1
兩下肢髖、膝及足踝關節均永久喪失機能者。 2 90%
9-4-2
兩下肢髖、膝及足踝關節中,各有二大關節永久喪失機能者。 3 80%
9-4-3
兩下肢髖、膝及足踝關節中,各有一大關節永久喪失機能者。 6 50%
9-4-4
一下肢髖、膝及足踝關節均永久喪失機能者。 6 50%
9-4-5
一下肢髖、膝及足踝關節中,有二大關節永久喪失機能者。 7 40%
9-4-6
一下肢髖、膝及足踝關節中,有一大關節永久喪失機能者。 8 30%
9-4-7
兩下肢髖、膝及足踝關節均永久遺存顯著運動障害者。 4 70%
9-4-8
兩下肢髖、膝及足踝關節中,各有二大關節永久遺存顯著運動障害
者。
5 60%
9-4-9
兩下肢髖、膝及足踝關節中,各有一大關節永久遺存顯著運動障害
者。
7 40%
9-4-10
一下肢髖、膝及足踝關節均遺存永久顯著運動障害者。 7 40%
9-4-11
一下肢髖、膝及足踝關節中,有二大關節永久遺存顯著運動障害者
。
8 30%
9-4-12
兩下肢髖、膝及足踝關節均永久遺存運動障害者。 6 50%
9-4-13
一下肢髖、膝及足踝關節均永久遺存運動障害者。 9 20%
足趾機能
障害
(註 14)
9-5-1
雙足十趾均永久喪失機能者。 7 40%
9-5-2
一足五趾均永久喪失機能者。 9 20%
註1:
1-1.於審定「神經障害等級」時,須有精神科、神經科、神經外科或復健科專科醫師診斷證明及相關檢驗報告
(如簡式智能評估表(MMSE)、失能評估表(modified Rankin Scale, mRS)、臨床失智評估量表(CDR)、神經
電生理檢查報告、神經系統影像檢查報告及相符之診斷檢查報告等)資料為依據,必要時保險人得另行指
定專科醫師會同認定。
(1)「為維持生命必要之日常生活活動」係指食物攝取、大小便始末、穿脫衣服、起居、步行、入浴等。
(2)有失語、失認、失行等之病灶症狀、四肢麻痺、錐體外路症狀、記憶力障害、知覺障害、感情障害、
意欲減退、人格變化等顯著障害;或者麻痺等症狀,雖為輕度,身體能力仍存,但非他人在身邊指
示,無法遂行其工作者:適用第 3 級。
(3)中樞神經系統障害,例如無知覺障害之錐體路及錐體外路症狀之輕度麻痺,依影像檢查始可證明之
輕度腦萎縮、腦波異常等屬之,此等症狀須據專科醫師檢查、診斷之結果審定之。
(4)中樞神經系統之頹廢症狀如發生於中樞神經系統以外之機能障害,應按其發現部位所定等級定之,
如障害同時併存時,應綜合其全部症狀擇一等級定之,等級不同者,應按其中較重者定其等級。
1-2.「平衡機能障害與聽力障害」等級之審定:因頭部損傷引起聽力障害與平衡機能障害同時併存時,